Trans-3-carboxymethylene-4-carboxy-5-methyl-delta2-isoxazoline as intermediate
US4499278A · kind A · utility
3Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 1982 |
| Grant date | Feb 12, 1985 |
| Priority date | — |
| Expiry date | Nov 22, 2002 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed is a process for the stereocontrolled total synthesis of thienamycin, which synthesis proceeds via intermediate II: ##STR1## wherein R.sup.5 and R.sup.6 are removable protecting groups.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.